Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care.

PubWeight™: 2.24‹?› | Rank: Top 2%

🔗 View Article (PMC 1861124)

Published in Heart on December 30, 2005

Authors

S DeWilde1, I M Carey, C Emmas, N Richards, D G Cook

Author Affiliations

1: Division of Community Health Sciences, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.

Articles citing this

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J (2013) 2.17

The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart (2013) 1.90

Status of the epidemiology of atrial fibrillation. Med Clin North Am (2008) 1.80

Prevalence and Risk Factors of Atrial Fibrillation in Chinese Elderly: Results from the Chinese Longitudinal Healthy Longevity Survey. Chin Med J (Engl) (2015) 1.51

The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study. Br J Gen Pract (2006) 1.47

A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart (2007) 1.44

Trends and inequities in beta-blocker prescribing for heart failure. Br J Gen Pract (2008) 1.41

Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000-2009. Heart (2012) 1.38

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation. Heart (2012) 1.05

Spurious trends in coronary heart disease incidence: unintended consequences of the new GP contract? Br J Gen Pract (2007) 0.96

Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis. BMC Public Health (2014) 0.90

Holmium Laser Enucleation of the Prostate: Comparison of Immediate Postoperative Outcomes in Patients with and without Antithrombotic Therapy. Curr Urol (2013) 0.89

An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes. J Am Heart Assoc (2013) 0.86

Antithrombotic treatment in atrial fibrillation. Heart (2006) 0.84

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers. BMC Cardiovasc Disord (2012) 0.83

Frequency and risk factors for under- and over-treatment in stroke prevention for patients with non-valvular atrial fibrillation in general practice. PLoS One (2013) 0.79

An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol. BMC Cardiovasc Disord (2013) 0.78

Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom. PLoS One (2013) 0.77

The efficacy of intraoperative atrial radiofrequency ablation for atrial fibrillation during concomitant cardiac surgery-the Surgical Atrial Fibrillation Suppression (SAFS) Study. J Interv Card Electrophysiol (2011) 0.76

A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study. BMC Cardiovasc Disord (2012) 0.76

Socioeconomic status influences the likelihood but not the outcome of liver resection for colorectal liver metastasis. HPB (Oxford) (2014) 0.75

Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014. PLoS One (2017) 0.75

Is quality of anticoagulation a 'wild card' in the treatment of patients with atrial fibrillation? Nat Clin Pract Cardiovasc Med (2007) 0.75

Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care. BMJ Open (2016) 0.75

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation. Cardiovasc Ther (2016) 0.75

Is self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluation. BMJ Open (2015) 0.75

European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation. Sci Rep (2016) 0.75

Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD. BMJ Open (2017) 0.75

Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation. Heart (2017) 0.75

Epidemiology and Management of Atrial Fibrillation and Stroke: Review of Data from Four European Countries. Stroke Res Treat (2017) 0.75

Articles cited by this

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93

Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet (1989) 10.18

The General Practice Research Database: quality of morbidity data. Popul Trends (1997) 7.07

Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol (1991) 6.55

Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ (2001) 6.32

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med (2002) 5.55

Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med (2000) 5.41

Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation (1991) 4.52

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet (1998) 4.19

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol (2001) 3.65

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. BMJ (1999) 3.62

Survey of equipment in general practice. BMJ (1989) 2.48

Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J (1996) 2.47

Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart (2001) 2.41

Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart (2003) 2.20

Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart (2002) 1.98

Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol (2002) 1.92

Developing a large electronic primary care database (Doctors' Independent Network) for research. Int J Med Inform (2004) 1.88

Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol (2003) 1.24

Inequalities in the treatment and control of hypertension: age, social isolation and lifestyle are more important than economic circumstances. J Hypertens (2001) 1.11

Implications of the problem orientated medical record (POMR) for research using electronic GP databases: a comparison of the Doctors Independent Network Database (DIN) and the General Practice Research Database (GPRD). BMC Fam Pract (2003) 0.98

How research-conscious GPs make decisions about anticoagulation in patients with atrial fibrillation: a qualitative study. Fam Pract (2004) 0.91

AFFIRM and RACE trials: implications for the management of atrial fibrillation. Card Electrophysiol Rev (2003) 0.84

Let's strip the king: eligibility not safety is the problem of anticoagulation for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med (2002) 0.83

Geriatric assessment and anticoagulation in elderly patients with chronic atrial fibrillation. Arch Intern Med (2000) 0.82

Articles by these authors

Using patient and general practice characteristics to explain variations in cervical smear uptake rates. BMJ (1994) 9.81

British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56

Prevalence of ischaemic heart disease in middle aged British men. Br Heart J (1984) 5.41

Patients' experiences and satisfaction with health care: results of a questionnaire study of specific aspects of care. Qual Saf Health Care (2002) 4.57

Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09

Using data from the 1991 census. BMJ (1995) 3.63

Home visiting by general practitioners in England and Wales. BMJ (1996) 3.31

Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax (1998) 3.19

Cardiovascular risk factors in British children from towns with widely differing adult cardiovascular mortality. BMJ (1996) 3.14

Loss of employment and mortality. BMJ (1994) 3.06

Health of unemployed middle-aged men in Great Britain. Lancet (1982) 2.94

Early influences on blood pressure: a study of children aged 5-7 years. BMJ (1989) 2.90

Sociodemographic variables for general practices: use of census data. BMJ (1995) 2.90

Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinat Epidemiol (2001) 2.85

Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71

Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart (1997) 2.65

An audit of peripheral catheter care in a teaching hospital. J Hosp Infect (1996) 2.61

Recall of diagnosis by men with ischaemic heart disease. Br Heart J (1984) 2.57

Explaining variation in hospital admission rates between general practices: cross sectional study. BMJ (1999) 2.56

Blood pressure in British children: associations with adult blood pressure and cardiovascular mortality. Lancet (1988) 2.51

Size at birth and blood pressure: cross sectional study in 8-11 year old children. BMJ (1997) 2.45

Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax (1997) 2.36

Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. BMJ (2000) 2.28

Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26

Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23

Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart (2003) 2.20

Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19

Health effects of passive smoking. 9. Parental smoking and spirometric indices in children. Thorax (1998) 2.16

What factors are associated with physical activity in older people, assessed objectively by accelerometry? Br J Sports Med (2008) 2.07

Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies. Int J Obes (Lond) (2009) 2.05

Is the clinical trial evidence about new drugs statistically adequate? Br J Clin Pharmacol (1985) 2.01

Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation. J Virol (1997) 1.98

Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart (2002) 1.98

Chronic exposure to outdoor air pollution and lung function in adults. Thorax (2009) 1.98

Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A (1993) 1.96

A critical review of the effect of factory closures on health. Br J Ind Med (1991) 1.95

C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis (2000) 1.90

Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment. Heart (2007) 1.87

Age of menarche in contemporary British teenagers: survey of girls born between 1982 and 1986. BMJ (2001) 1.81

Classical versus non-renal Wegener's granulomatosis. Q J Med (1994) 1.79

The Dinamap 1846SX automated blood pressure recorder: comparison with the Hawksley random zero sphygmomanometer under field conditions. J Epidemiol Community Health (1992) 1.77

ABO blood group and ischaemic heart disease in British men. BMJ (1990) 1.76

Home environment and severe asthma in adolescence: a population based case-control study. BMJ (1995) 1.76

The effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord (1999) 1.72

Non-employment and changes in smoking, drinking, and body weight. BMJ (1992) 1.68

Do maternal and intrauterine factors influence blood pressure in childhood? Arch Dis Child (1992) 1.66

Chronic manganese intoxication. Arch Neurol (1974) 1.61

Health and social precursors of unemployment in young men in Great Britain. J Epidemiol Community Health (1996) 1.60

Time trends in respiratory symptoms in childhood over a 24 year period. Arch Dis Child (1993) 1.55

Passive smoking and sudden infant death syndrome: review of the epidemiological evidence. Thorax (1997) 1.55

Flow-mediated dilation in 9- to 11-year-old children: the influence of intrauterine and childhood factors. Circulation (1997) 1.54

Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation (2000) 1.53

Effect of fresh fruit consumption on lung function and wheeze in children. Thorax (1997) 1.53

Infections presenting for clinical care in early life and later risk of hay fever in two UK birth cohorts. Allergy (2008) 1.52

Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J (1986) 1.49

Socio-economic determinants of casualty and NHS Direct use. J Public Health (Oxf) (2008) 1.46

British South Asians aged 13-16 years have higher fasting glucose and insulin levels than Europeans. Diabet Med (2005) 1.46

D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet (1981) 1.45

Timing of routine immunisations and subsequent hay fever risk. Arch Dis Child (2005) 1.45

Do children who become autistic consult more often after MMR vaccination? Br J Gen Pract (2001) 1.44

Annual night visiting rates in 129 general practices in one family health services authority: association with patient and general practice characteristics. Br J Gen Pract (1995) 1.43

Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42

Unemployment pre-dates symptoms of depression and anxiety resulting in medical consultation in young men. Int J Epidemiol (1999) 1.40

Monitoring the frequency of side effects of drugs. Reasons for stopping drugs could be recorded in general practice. BMJ (1996) 1.39

Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy. Ann Rheum Dis (1988) 1.38

Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation (2005) 1.37

Health effects of passive smoking .5. Parental smoking and allergic sensitisation in children. Thorax (1998) 1.35

Short stature, lung function and risk of a heart attack. Int J Epidemiol (1989) 1.33

Episodic evolution of pyrin in primates: human mutations recapitulate ancestral amino acid states. Nat Genet (2001) 1.33

Effects of changes in fresh fruit consumption on ventilatory function in healthy British adults. Am J Respir Crit Care Med (1998) 1.33

Non-participation and mortality in a prospective study of cardiovascular disease. J Epidemiol Community Health (1987) 1.32

Do general practitioners influence the uptake of breast cancer screening? J Med Screen (1995) 1.29

Maternal cotinine level during pregnancy and birthweight for gestational age. Int J Epidemiol (1998) 1.29

Relapses in patients with a systemic vasculitis. Q J Med (1993) 1.27

Health effects of passive smoking. 4. Parental smoking, middle ear disease and adenotonsillectomy in children. Thorax (1998) 1.26

Physical activity, obesity and cardiometabolic risk factors in 9- to 10-year-old UK children of white European, South Asian and black African-Caribbean origin: the Child Heart And health Study in England (CHASE). Diabetologia (2010) 1.21

Childhood size is more strongly related than size at birth to glucose and insulin levels in 10-11-year-old children. Diabetologia (1997) 1.21

Age and sex differences in the management of ischaemic heart disease. Public Health (1996) 1.21

A comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women. Clin Sci (Lond) (1994) 1.19

Nutritional composition of the diets of South Asian, black African-Caribbean and white European children in the United Kingdom: the Child Heart and Health Study in England (CHASE). Br J Nutr (2010) 1.19

Leukocyte count and risk of major coronary heart disease events. Am J Epidemiol (1992) 1.17

Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease. Neurology (2006) 1.16

Social class and height. BMJ (1988) 1.16

Multiple regression in geographical mortality studies, with allowance for spatially correlated errors. Biometrics (1983) 1.15

The effects of environmental tobacco smoke exposure on lung function in a longitudinal study of British adults. Epidemiology (1999) 1.12

Plasma vitamin C levels in men and women from different ethnic backgrounds living in England. Int J Epidemiol (1999) 1.12

Inequalities in the treatment and control of hypertension: age, social isolation and lifestyle are more important than economic circumstances. J Hypertens (2001) 1.11

Blood pressure measurement in children: the importance of cuff bladder size. J Hypertens (1989) 1.11